Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 495-501

  Seam, Nitin ^a,c   Meduri, G Umberto ^b   Wang, Honghui ^c   Nylen, Eric S ^a   Sun, Junfeng ^c   Schultz, Marcus J ^d   Tropea, Margaret ^c   Suffredini, Anthony F ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

ARDS; coagulation; corticosteroids; inflammation; proadrenomedullin; protein C

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; METHYLPREDNISOLONE; PLACEBO; PROADRENOMEDULLIN; PROCALCITONIN; PROTEIN C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANGIOGENESIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TREATMENT DURATION;

BLOOD COAGULATION; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INFLAMMATION MEDIATORS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERENCE VALUES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856146205     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318232da5e     Document Type: Article

References (36)

1. Meduri GU, Golden E, Freire AX, et al: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 2007; 131:954-963
2. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
3. Meduri GU, Kohler G, Headley S, et al: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-1314
4. Meduri GU, Muthiah MP, Carratu P, et al: Nuclear factor-kappaB-and glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflam-mation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12:321-338
5. Parsons PE, Eisner MD, Thompson BT, et al: Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1-6; discussion 230-232
6. McClintock D, Zhuo H, Wickersham N, et al: Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 2008; 12:R41
7. Sinclair S, Bijoy J, Golden E, et al: Interleukin-8 and soluble intercellular adhesion molecule-1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment. Minerva Pneumologica 2006; 45:93-104
8. Steinberg KP, Milberg JA, Martin TR, et al: Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:113-122
9. Meduri GU, Tolley EA, Chinn A, et al: Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998; 158:1432-1441
10. Meduri GU: The role of the host defence response in the progression and outcome of ARDS: Pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 1996; 9:2650-2670
11. Cordier J-F, Peyrol S, Loire R: Bronchiolitis obliterans organizing pneumonia as a model of inflammatory lung disease. In: Diseases of the Bronchioles. Epler G (Ed). New York, Raven Press, Ltd., 1994, pp 313-345
12. Pelosi P, Caironi P, Gattinoni L: Pulmonary and extrapulmonary forms of acute respiratory distress syndrome. Semin Respir Crit Care Med 2001; 22:259-268
13. Meduri GU, Marik PE, Chrousos GP, et al: Steroid treatment in ARDS: A critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008; 34:61-69
14. Tang BM, Craig JC, Eslick GD, et al: Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care Med 2009; 37:1594-1603
15. Marik PE, Pastores SM, Annane D, et al: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949
16. Bastarache JA, Ware LB, Bernard GR: The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome. Semin Respir Crit Care Med 2006; 27:365-376
17. Idell S, James KK, Levin EG, et al: Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84:695-705
18. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308
19. Little RJA, Rubin DB: Statistical Analysis With Missing Data. Hoboken, NJ, John W. Wiley and Sons, 2002
20. Koo DJ, Yoo P, Cioffi WG, et al: Mechanism of the beneficial effects of pentoxifylline during sepsis: Maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J Surg Res 2000; 91:70-76
21. Mosnier LO, Zlokovic BV, Griffin JH: The cytoprotective protein C pathway. Blood 2007; 109:3161-3172
22. Toltl LJ, Beaudin S, Liaw PC: Activated protein C up-regulates IL-10 and inhibits tissue factor in blood monocytes. J Immunol 2008; 181:2165-2173
23. Weiler H: Regulation of inflammation by the protein C system. Crit Care Med 2010; 38(Suppl):S18-S25
24. Hataji O, Taguchi O, Gabazza EC, et al: Activation of protein C pathway in the airways. Lung 2002; 180:47-59
25. Hofstra JJ, Juffermans NP, Schultz MJ, et al: Pulmonary coagulopathy as a new target in lung injury-A review of available pre-clinical models. Curr Med Chem 2008; 15:588-595
26. Ware LB, Matthay MA, Parsons PE, et al: Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 35:1821-1828
27. Liu KD, Levitt J, Zhuo H, et al: Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008; 178:618-623
28. Costallat LT, Ribeiro CC, Annichino-Bizzacchi JM: Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus. Sangre (Barc) 1998; 43:345-348
29. Oner AF, Bay A, Kuru M, et al: Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura. Clin Appl Thromb Hemost 2005; 11:489-492
30. Ueda N: Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome. Nephron 1990; 56:374-378
31. Kellum JA, Kong L, Fink MP, et al: Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007; 167: 1655-1663
32. Oppert M, Schindler R, Husung C, et al: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464
33. Guignant C, Voirin N, Venet F, et al: Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 2009; 35:1859-1867
34. Kruger S, Ewig S, Giersdorf S, et al: Cardiovascular and inflammatory biomarkers to predict short-and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010; 182:1426-1434
35. de Kruif MD, Lemaire LC, Giebelen IA, et al: The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 2008; 34:518-522
36. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824